Xiawei Wei
Huawei Technologies (China)(CN)Sichuan University(CN)West China Hospital of Sichuan University(CN)Ruikang Affiliated Hospital of Guangxi Medical University(CN)State Key Laboratory of BiotherapyBank of China(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Immunotherapy and Immune Responses, Immune cells in cancer, RNA Interference and Gene Delivery, COVID-19 Clinical Research Studies
Most-Cited Works
- → Targeting PI3K in cancer: mechanisms and advances in clinical trials(2019)1,535 cited
- → Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials(2019)1,078 cited
- → The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis(2022)919 cited
- → A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity(2020)841 cited
- → Cancer vaccines as promising immuno-therapeutics: platforms and current progress(2022)665 cited
- → A mouse model for SARS-CoV-2-induced acute respiratory distress syndrome(2021)634 cited